Cargando…
Ischemic Stroke and Savings in Time to Achieve Functional Recovery: Experience from NeuroAiD
Despite recent progress with revascularisation interventions after acute ischemic stroke, many patients remain disabled after stroke. Using data from a multi-centre, randomised, double-blind, placebo-controlled trial of a neuro-repair treatment (NeuroAiD/MLC601) with a long-term follow-up, we analys...
Autores principales: | Venketasubramanian, Narayanaswamy, Pokharkar, Yogesh, Chai, Jia Hui, Chen, Christopher Li Hsian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059584/ https://www.ncbi.nlm.nih.gov/pubmed/36975881 http://dx.doi.org/10.3390/jcdd10030117 |
Ejemplares similares
-
The NeuroAiD Safe Treatment (NeST) Registry: a protocol
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015) -
The value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD)
por: Venketasubramanian, Narayanaswamy, et al.
Publicado: (2015) -
Safety and Use of MLC601/MLC901 (NeuroAiD(TM)) in Primary Intracerebral Hemorrhage: A Cohort Study from the NeuroAiD Safe Treatment Registry
por: Kumar, Ramesh, et al.
Publicado: (2020) -
The Use of NeuroAiD (MLC601) in Postischemic Stroke Patients
por: Navarro, Jose C., et al.
Publicado: (2012) -
Spinal cord injury – assessing tolerability and use of combined rehabilitation and NeuroAiD (SATURN) study – primary results of an exploratory study
por: Kumar, Ramesh, et al.
Publicado: (2022)